TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35221706

Group type: EXPERIMENTAL
Intervention: Ethosuximide plus mebeverine
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Pentoxifylline plus mebeverine
Number of subjects: 150

Group type: COMPARATOR
Intervention: Mebeverine
Number of subjects: 150
Study: 32618034

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) education program during two face‐to‐face sessions, along with routine health education (two 1‐h lectures) over a 2‐wk period
Number of subjects: 112

Group type: COMPARATOR
Intervention: Routine health education (two 1‐h lectures)
Number of subjects: 112
Study: 35631279

Group type: EXPERIMENTAL
Intervention: EGG (two eggs per day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: SUB (egg substitute)
Number of subjects: 30
Study: 33259720

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 60
Study: 35683985

Group type: EXPERIMENTAL
Intervention: Test-and-treat approach for intestinal parasites at the individual level
Number of subjects: 121

Group type: COMPARATOR
Intervention: Annual albendazole at the individual level
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: All arms (including test-and-treat and albendazole)
Number of subjects: 121
Study: 32393194

Group type: EXPERIMENTAL
Intervention: Women with a longstanding mental health condition
Number of subjects: 4787

Group type: COMPARATOR
Intervention: Women without a longstanding mental health condition
Number of subjects: 4787
Study: 32515891

Group type: EXPERIMENTAL
Intervention: Endurance Training Group (ETG)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Strength Training Group (STG)
Number of subjects: 77
Study: 33021938

Group type: EXPERIMENTAL
Intervention: Proposed method for interpreting deep image classifiers using discrete masks and generative adversarial networks.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proposed method for interpreting deep image classifiers.
Number of subjects: 0
Study: 35022958

Group type: EXPERIMENTAL
Intervention: ACO
Number of subjects: 23643

Group type: COMPARATOR
Intervention: Non-ACO
Number of subjects: 23643
Study: 32985240

Group type: EXPERIMENTAL
Intervention: Maxillary protraction therapy in UCLP group
Number of subjects: 52

Group type: COMPARATOR
Intervention: Maxillary protraction therapy in noncleft group
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Maxillary protraction therapy in both groups
Number of subjects: 52
Study: 32375104

Group type: EXPERIMENTAL
Intervention: Fulacimstat 25 mg twice daily for 6 months
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 95148513

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 35531757

Group type: EXPERIMENTAL
Intervention: Lidocaine (20 mL of 2% solution)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Tramadol (2 mg/kg)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 99
Study: 34749782

Group type: EXPERIMENTAL
Intervention: Magnetic Seizure Therapy (MST), administered 2-3 days per week over seven weeks, maximum of 21 treatments.
Number of subjects: 260

Group type: COMPARATOR
Intervention: Right unilateral ultra-brief pulse width electroconvulsive therapy (RUL-UB-ECT), administered 2-3 days per week over seven weeks, maximum of 21 treatments.
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: MST or RUL-UB ECT (both groups),
Number of subjects: 260
Study: 34656515

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) therapy at 4 points with a diode laser at 810 nm wavelength, 6 J (100 mW, 60 seconds/point)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) therapy
Number of subjects: 13

Group type: COMPARATOR
Intervention: SHAM (laser irradiation simulation)
Number of subjects: 13
Study: 35261590

Group type: EXPERIMENTAL
Intervention: 20 mL of 0.375% bupivacaine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 25 mL of 0.375% bupivacaine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 30 mL of 0.375% bupivacaine
Number of subjects: 60
Study: 32674604

Group type: EXPERIMENTAL
Intervention: Aerobic, resistance, and combined training
Number of subjects: 104
Study: 33377343

Group type: EXPERIMENTAL
Intervention: CO2 fractional laser treatment
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control group (post-cheiloplasty)
Number of subjects: 113
Study: 35969212

Group type: EXPERIMENTAL
Intervention: Acrylic resin anterior bite plane (ABP)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Thermoplastic materials anterior bite plane (TBP)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Comparison between ABP and TBP
Number of subjects: 34
Study: 34256171

Group type: EXPERIMENTAL
Intervention: Endodontic therapy with MPQ, intracanal medication, and 2 applications of aPDT (0.005% methylene blue, 660 nm, 90 seconds)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Endodontic Therapy with Mechanical Chemical Preparation (MPQ) and intracanal medication
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: aPDT
Number of subjects: 50
Study: 32516821

Group type: EXPERIMENTAL
Intervention: Provider interaction in rehabilitation setting
Number of subjects: 618

Group type: EXPERIMENTAL
Intervention: Provider interaction in medical setting
Number of subjects: 618

Group type: EXPERIMENTAL
Intervention: Provider interaction in consumer electronics setting
Number of subjects: 618

Group type: COMPARATOR
Intervention: Preappointment responses (control condition)
Number of subjects: 618
Study: 35060200

Group type: EXPERIMENTAL
Intervention: S1
Number of subjects: 64

Group type: COMPARATOR
Intervention: S2
Number of subjects: 64
Study: 32340800

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 57

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 57
Study: 36459119

Group type: EXPERIMENTAL
Intervention: Etanercept monotherapy
Number of subjects: 253

Group type: COMPARATOR
Intervention: Methotrexate monotherapy
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Patients with disease worsening
Number of subjects: 253

Group type: COMPARATOR
Intervention: Patients without disease worsening
Number of subjects: 253
Study: 33197677

Group type: EXPERIMENTAL
Intervention: d3RP-NF2 program
Number of subjects: 45

Group type: COMPARATOR
Intervention: Health-Enhancement program (Control)
Number of subjects: 45
Study: 34302588

Group type: EXPERIMENTAL
Intervention: Listening to the recitation of the Surah Al‐Inshirah during labor
Number of subjects: 126
Study: 34543779

Group type: EXPERIMENTAL
Intervention: 4 weeks of antiseizure medication (ASM)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 12 weeks of antiseizure medication (ASM)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 4 weeks of ASM
Number of subjects: 60

Group type: COMPARATOR
Intervention: 12 weeks of ASM
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Children with disabilities at randomization
Number of subjects: 60
Study: 34894161

Group type: EXPERIMENTAL
Intervention: Majority-message condition
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Minority-message condition
Number of subjects: 158

Group type: COMPARATOR
Intervention: No-message condition
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Social Dominance Orientation (SDO)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Inclusive Work Environment (IWC)
Number of subjects: 158
Study: 32064691

Group type: EXPERIMENTAL
Intervention: Active kava-drinking participants
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control participants
Number of subjects: 40
Study: 34860318

Group type: EXPERIMENTAL
Intervention: Ipatasertib plus paclitaxel
Number of subjects: 222

Group type: COMPARATOR
Intervention: Placebo plus paclitaxel
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Ipatasertib
Number of subjects: 222

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 222
Study: 35599000

Group type: EXPERIMENTAL
Intervention: Prasugrel (3.75 mg/day)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Clopidogrel (75 mg/day)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 230

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 230
Study: 33874660

Group type: EXPERIMENTAL
Intervention: Metronidazole placement into gingival pockets; General therapy with Calcemin
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Mixture of metronidazole and Eplan; General therapy with alendronate and alphacalcidolum
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Eplan and alendronate and alphacalcidolum based medicines
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 68
Study: 35141811

Group type: EXPERIMENTAL
Intervention: Clonazepam 0.5 mg 30 min before bedtime for 4 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Prolonged-release melatonin 2 mg 30 min before bedtime for 4 weeks
Number of subjects: 34
Study: 34423487

Group type: EXPERIMENTAL
Intervention: IVF-ET in patients with uterus didelphys
Number of subjects: 83
Study: 32668499

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTA) injection
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0.9% normal saline (control)
Number of subjects: 30
Study: 36435664

Group type: EXPERIMENTAL
Intervention: CUdent/extra soft
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CUdent/soft
Number of subjects: 30

Group type: COMPARATOR
Intervention: Colgate
Number of subjects: 30

Group type: COMPARATOR
Intervention: GoodAge
Number of subjects: 30
Study: 33626291

Group type: EXPERIMENTAL
Intervention: CYD‐TDV booster (n=89)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo (n=29)
Number of subjects: 118
Study: 32687081

Group type: EXPERIMENTAL
Intervention: Entropy monitoring (Group II)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional clinical monitoring (Group I)
Number of subjects: 60
Study: 33249884

Group type: EXPERIMENTAL
Intervention: Ultra-Orthodox Jewish women
Number of subjects: 239
Study: 34535631

Group type: EXPERIMENTAL
Intervention: Imaginal retraining with movement
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Imaginal retraining without movement
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Imaginal retraining (both conditions combined)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Imaginal retraining (with and without movement)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Thought suppression
Number of subjects: 113

Group type: COMPARATOR
Intervention: Merely observing a picture
Number of subjects: 113
Study: 33181641

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral reflective training (CBRT)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Waitlisted control group
Number of subjects: 167
Study: 34582670

Group type: COMPARATOR
Intervention: CCRT with weekly cisplatin followed by observation (arm A)
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: ACT with paclitaxel plus carboplatin every 4 weeks for 3 cycles (arm B)
Number of subjects: 259
Study: 32989541

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 190

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 190
Study: 33198876

Group type: EXPERIMENTAL
Intervention: Cuff pressure at 30 cmH2O
Number of subjects: 90

Group type: COMPARATOR
Intervention: Cuff pressure at 20 cmH2O
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Cuff pressure at 25 cmH2O
Number of subjects: 90
Study: 35352605

Group type: EXPERIMENTAL
Intervention: VR 'walk in the woods'
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: VR 'forest of focus'
Number of subjects: 24

Group type: COMPARATOR
Intervention: Computer screen 'forest of focus'
Number of subjects: 24

Group type: COMPARATOR
Intervention: Computer screen 'walk in the woods'
Number of subjects: 24
Study: 34281467

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metformin or ILI
Number of subjects: 0
Study: 32978029

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided puncture
Number of subjects: 194

Group type: COMPARATOR
Intervention: Anatomical landmark-guided puncture
Number of subjects: 194
Study: 34655087

Group type: COMPARATOR
Intervention: Propofol (2 mg/kg intravenously, maintained at 5 mg/kg/h)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Low-dose remimazolam tosylate (0.25 mg/kg intravenously, maintained at 0.48 mg/kg/h)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: High-dose remimazolam tosylate (0.25 mg/kg intravenously, maintained at 0.6 mg/kg/h)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Remimazolam tosylate (both doses)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Both remimazolam tosylate and propofol
Number of subjects: 90
Study: 32789656

Group type: EXPERIMENTAL
Intervention: Pro Seal® (PS)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Opal® Seal™ (OS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both sealants (PS and OS)
Number of subjects: 20
Study: 32331087

Group type: EXPERIMENTAL
Intervention: 200 mg SPN-812
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: 400 mg SPN-812
Number of subjects: 310

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 310
Study: 36105449

Group type: EXPERIMENTAL
Intervention: Edaravone treatment
Number of subjects: 200

Group type: COMPARATOR
Intervention: Mailuoning injection treatment
Number of subjects: 200
Study: 32961410

Group type: EXPERIMENTAL
Intervention: Oxytocin (24 IU intranasal)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193
Study: 32967701

Group type: EXPERIMENTAL
Intervention: Lower weightbearing ankle dorsiflexion range of motion
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Higher FPI scores (more pronated foot posture)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Greater midfoot mobility
Number of subjects: 188
Study: 34459569

Group type: EXPERIMENTAL
Intervention: Salt substitute (75% sodium chloride and 25% potassium chloride by mass)
Number of subjects: 20995

Group type: COMPARATOR
Intervention: Regular salt (100% sodium chloride)
Number of subjects: 20995
Study: 35414566

Group type: EXPERIMENTAL
Intervention: HUG-5 tool administered periodically in an outpatient clinic using a semi-automated workflow
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HUG-5 and GlauQoL-17
Number of subjects: 0

Group type: COMPARATOR
Intervention: Frequency of calls
Number of subjects: 0
Study: 34332762

Group type: EXPERIMENTAL
Intervention: EIT‐4‐BPSD implementation strategy
Number of subjects: 553

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 553
Study: 33686027

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate (SH)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Corticosteroids (CS)
Number of subjects: 30
Study: 33741314

Group type: EXPERIMENTAL
Intervention: Multiple Plastic Stents (MPS)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Fully Covered Self-Expanding Metal Stent (FCSEMS)
Number of subjects: 164
Study: 32526771

Group type: EXPERIMENTAL
Intervention: Incremental oxygen uptake test on a treadmill before starting (neo-)adjuvant treatment and an exercise intervention
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Cut-points for variables associated with the test leader's evaluation
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Maximal heart rate and oxygen uptake plateau
Number of subjects: 535
Study: 37728450

Group type: EXPERIMENTAL
Intervention: 20 mg of bupivacaine with 75 mcg of clonidine
Number of subjects: 64

Group type: COMPARATOR
Intervention: 20 mg of bupivacaine
Number of subjects: 64
Study: 33893705

Group type: EXPERIMENTAL
Intervention: Propofol-based TIVA
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control (inhaled sevoflurane anaesthesia)
Number of subjects: 130
Study: 34022945

Group type: EXPERIMENTAL
Intervention: Serious game training without seeing myosignals
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Visual myosignal training
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group using touchpad
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both experimental groups
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Clinically relevant measure 'accuracy'
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Feature of the myosignals 'variation in phasing'
Number of subjects: 28
Study: 32202505

Group type: EXPERIMENTAL
Intervention: MamaKits online (5-week guided internet intervention)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Treatment as usual (control condition)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: MamaKits online
Number of subjects: 159
Study: 36317958

Group type: EXPERIMENTAL
Intervention: Cangrelor (bolus and infusion for 2 hours)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cangrelor
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cangrelor and Placebo
Number of subjects: 20
Study: 33864607

Group type: EXPERIMENTAL
Intervention: Testosterone treatment, n = 6
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo treatment, n = 8
Number of subjects: 14
Study: 35314958

Group type: EXPERIMENTAL
Intervention: Resistance Training Group (RTG) - two sessions/week for 12 weeks plus instructions to undertake ≥ 10,000 steps/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control Group (CG) - ≥ 10,000 steps/day only
Number of subjects: 60
Study: 34068824

Group type: EXPERIMENTAL
Intervention: Frequent drinking (especially heavy drinking)
Number of subjects: 12937

Group type: EXPERIMENTAL
Intervention: Average amount of alcohol consumed weekly (in frequent drinkers with obesity)
Number of subjects: 12937

Group type: COMPARATOR
Intervention: Never or infrequent drinkers
Number of subjects: 12937

Group type: COMPARATOR
Intervention: Frequent drinkers
Number of subjects: 12937
Study: 36000743

Group type: EXPERIMENTAL
Intervention: Soft palate closure at 4 months and hard palate closure at 12 months (Arm A)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Closure of both the soft and hard palate at 12 months (Arm C)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Both surgical methods
Number of subjects: 79
Study: 34366153

Group type: EXPERIMENTAL
Intervention: Henagliflozin 10 mg in the fasted condition
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Henagliflozin 10 mg in the fed condition
Number of subjects: 12

Group type: COMPARATOR
Intervention: Comparison of fasted vs fed conditions
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Henagliflozin in fasted state
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Henagliflozin in fed state
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High-fat meal prior to henagliflozin administration
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Overall mass balance of henagliflozin
Number of subjects: 12
Study: 33546681

Group type: COMPARATOR
Intervention: Alcohol dependence vignette
Number of subjects: 1414

Group type: COMPARATOR
Intervention: Depression vignette
Number of subjects: 1414
Study: 34212234

Group type: EXPERIMENTAL
Intervention: Diode laser (980 nm)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Topical corticosteroid (0.1% triamcinolone acetonide)
Number of subjects: 50
Study: 34023739

Group type: EXPERIMENTAL
Intervention: Tai Chi (TC)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Group walking
Number of subjects: 81

Group type: COMPARATOR
Intervention: Usual care control (UC)
Number of subjects: 81
Study: 32586526

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 250

Group type: COMPARATOR
Intervention: Losartan
Number of subjects: 250
Study: 34128236

Group type: EXPERIMENTAL
Intervention: Cool Little Kids parenting group programme
Number of subjects: 545

Group type: COMPARATOR
Intervention: Usual care access to available support services
Number of subjects: 545
Study: 33846016

Group type: EXPERIMENTAL
Intervention: Statin use after diagnosis
Number of subjects: 15703

Group type: EXPERIMENTAL
Intervention: Statin use after diagnosis (type 1 cancers)
Number of subjects: 15703

Group type: EXPERIMENTAL
Intervention: Hydrophilic statins after diagnosis
Number of subjects: 15703

Group type: EXPERIMENTAL
Intervention: New use of statins after diagnosis
Number of subjects: 15703

Group type: EXPERIMENTAL
Intervention: Increasing number of statin prescriptions
Number of subjects: 15703
Study: 35178234

Group type: EXPERIMENTAL
Intervention: TCM acupuncture
Number of subjects: 84

Group type: COMPARATOR
Intervention: Rehabilitation training (Control)
Number of subjects: 84
Study: 34114493

Group type: EXPERIMENTAL
Intervention: Cellular medicine trials (including stem cell therapy) for COVID-19
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: COVID-19 cellular medicine trials
Number of subjects: 0
Study: 35775704

Group type: EXPERIMENTAL
Intervention: Conventional photodynamic therapy (c-PDT)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Daylight photodynamic therapy (dl-PDT)
Number of subjects: 50
Study: 32840059

Group type: EXPERIMENTAL
Intervention: 3-D visualization helmet (3DVH)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Standard Galilean microscope (GM)
Number of subjects: 184
Study: 33739874

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance exercise
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control
Number of subjects: 140
Study: 32555096

Group type: EXPERIMENTAL
Intervention: Bio-composite suture anchor (glycolic polylactic acid anchors, beta‐tricalcium phosphate and calcium sulphate)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Open-construct (PEEK) suture anchor
Number of subjects: 33
Study: 36121143

Group type: EXPERIMENTAL
Intervention: Hypoxic high-volume HIIT (H-HIIT)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Normoxic HIIT (N-HIIT)
Number of subjects: 31
Study: 34326476

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 32469304

Group type: EXPERIMENTAL
Intervention: L-carnitine and piracetam (10 mL of a solution containing L-carnitine 100 mg/mL + piracetam 80 mg/mL)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: L-carnitine and piracetam
Number of subjects: 61
Study: 35386730

Group type: EXPERIMENTAL
Intervention: Dialectical Behaviour Therapy for PTSD (DBT-PTSD)
Number of subjects: 14
Study: 36221089

Group type: EXPERIMENTAL
Intervention: Smoke-free home (SFH) intervention delivered in mosques
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Indoor air quality (IAQ) feedback
Number of subjects: 900

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 900